A multicentre implementation trial of an Artificial Intelligence-driven biomarker to inform Shared decisions for androgen deprivation therapy in men undergoing prostate radiotherapy: the ASTuTE protocol

Table 2 Schedule of assessments (according to SPIRIT-AI extension)

	Enrolment / Pre-test¹	Post-test²	5-year follow-up
1. Demographics	X
2. Prostate cancer history	X
3. Shared ADT decision recommendation as determined by primary clinician and participant	X	X
4. EPIC-26 Quality of Life questionnaire	X³		X³
5. Disease Control			X³

¹Enrolment / pre-test can happen over a period of 14 days
²Post-test data collection may occur at initial consult if ArteraAI Prostate Test results are available
³Data linkage through Prostate Cancer Outcomes Registry at median 5-year follow-up.

ISSN: 1471-2407